BTMD Stock Analysis: Buy, Sell, or Hold?
BTMD - Biote Corp. Class A Common Stock
$2.09
0.00 (0.00%)
▲
HOLD
LOW Confidence
Last Updated: January 30, 2026
Earnings: Mar 11, 2026
Get Alerted When BTMD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: BTMD shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: BTMD shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$4.71
Based on 13.1% avg growth
INTRINSIC VALUE TODAY
$2.93
28.6% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 3.1x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: BTMD is currently trading at $2.09, which is considered oversold relative to its 30-day fair value range of $2.21 to $2.61. From a valuation perspective, the stock is trading at a discount (Forward PE: 2.5) compared to its historical average (3.1). Remarkably, the market is currently pricing in an annual earnings decline of 6.3% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, BTMD is in a strong downtrend. The price is currently testing key support at $2.03. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $4.21 (+101.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, BTMD is in a strong downtrend. The price is currently testing key support at $2.03. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $4.21 (+101.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$2.21 -
$2.61
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
79.5%
Protect Your Profits
Holding BTMD? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 101.5% below Wall St target ($4.21)
- CAUTION: Recommendation downgraded due to -5.4% 5-day decline
Fair Price Analysis
30-Day Fair Range
$2.21 -
$2.61
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$2.03
Resistance Level
$2.42
Current Trend
Strong Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
2.52
Wall Street Target
$4.21
(+101.5%)
Revenue Growth (YoY)
-6.7%
Earnings Growth (YoY)
-33.3%
Profit Margin
14.7%
Valuation Discount vs History
-6.3% cheaper
PE vs Historical
2.5 vs 3.1
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-6.3%
(market-implied from PE analysis)
1-Year Target
$1.96
(-6%)
2-Year Target
$1.83
(-12%)
3-Year Target
$1.72
(-18%)
3-Yr Target (if PE normalizes)
(PE: 3→3)
$2.12
(+1%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.3, Growth: 22.1%)
$33.66
(+1510%)
Base:
(SPY PE: 2.5, Growth: 22.1%)
$3.80
(+82%)
Bear:
(PE: 2.1, Growth: 22.1%)
$3.23
(+55%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (3x PE), but valuation improves significantly next year (3x PE) as earnings recover.
Trailing PE: 2.62 | Current EPS (TTM): $0.79
Bull Case
$2.39
(+15%)
Analyst growth 5.1%, PE expands to 2.9
Base Case
$2.17
(+4%)
Market implied 5.1%, PE stable at 2.6
Bear Case
$1.41
(-33%)
Severe decline -20.0%, PE contracts to 2.2
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 2.5 to 3.1
Stabilization Target:
$2.57
(+23.1%)
PE Expansion Potential:
+23.1%
Last updated: January 31, 2026 2:49 PM ET
Data refreshes hourly during market hours. Next update: 3:49 PM
Data refreshes hourly during market hours. Next update: 3:49 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BTMD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
HCA
HCA Holdings Inc |
BUY
25 analysts |
$489 | 63 BUY |
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
22 analysts |
$238 | 54 HOLD |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$140 | 54 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$17 | 52 HOLD |
|
CON
Concentra Group Holdings… |
STRONG BUY
8 analysts |
$28 | 62 BUY |
Advanced BTMD Option Strategies
Professional options setups generated by AI based on today's BTMD price and gamma walls.
